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“...Rewritten in the Skin”: Clues to Skin Biology and Aging
from Inherited Disease
Raymond J. Monnat Jr1
The growing diversity of heritable skin diseases, a
practical challenge to clinicians and dermato-
nosologists alike, has nonetheless served as a rich
source of insight into skin biology and disease mechan-
isms. I summarize below some key insights from the
recent gene-driven phase of research on Werner
syndrome, a heritable adult progeroid syndrome with
prominent dermatologic features, constitutional geno-
mic instability, and an elevated risk of cancer. I also
indicate how new insights into skin biology, disease, and
aging may come from unexpected sources.
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INTRODUCTION
Werner syndrome (WS) is an autosomal recessive disease that
ﬁrst captured wide attention owing to its prominent premature
aging (or progeroid) features. WS is also of considerable
biomedical science interest in light of the pairing of these
progeroid features with constitutional genomic instability and
an elevated risk of many clinically important, age-dependent
human diseases.
The progeroid features of WS were ﬁrst well described by
Werner (1985), who described a North German family of four
siblings, aged 31–40 years, with short stature, prematurely
gray hair, bilateral cataracts, atrophy of the extremities,
hyperkeratosis, and scleroderma-like changes together with
foot and ankle skin ulceration. He noted that one of the
siblings, a 36-year-old man, gave “...the impression of
extreme senility.” These observations were published as part
of Werner’s doctoral thesis before his embarking on a career
in a small North Sea village. Werner never again returned to
study his syndrome (Pehmoeller, 2001).
The term “Werner’s syndrome” was ﬁrst used in a
subsequent report of an additional patient who resembled the
family members seen by Werner (Oppenheimer and Kugel,
1934). This case report together with a more comprehensive
study by Thannhauser of ﬁve additional patients (Thannhauser,
1945) provided a detailed description of WS. WS was next
“rediscovered” by colleagues at the University of Washington,
who described three Japanese-American sisters with WS (one
of whom is shown in Figure 1). Their analysis established the
autosomal recessive inheritance of WS and delineated key
differences between WS and normal aging (Epstein et al.,
1966).
WS AS A CLINICAL ENTITY
The most consistent and earliest noted ﬁndings are premature
graying and loss of hair together with bilateral cataracts, short
stature, and progressive, scleroderma-like skin changes
(Table 1; Epstein et al., 1966; Tollefsbol and Cohen, 1984;
Goto, 1997). Hair graying and loss begin in the second
decade with the scalp and eyebrows, as do bilateral ocular
cataracts. The short stature of WS patients reﬂects the absence
of a pubertal growth spurt. Short stature together with
progressive limb thinning, atrophy, and a stocky trunk give
many patients a “cushingoid” appearance (see Figure 2 in
Goto (2001)).
The scleroderma-like skin changes of WS (Thannhauser,
1945) consist of a mix of atrophic and proliferative changes:
epidermal atrophy that includes skin appendages in
conjunction with focal hyperkeratosis and basal
hypermelanosis. Dermal subcutaneous atrophy is often found
with dermal ﬁbrosis underlying atrophic skin (Thannhauser,
1945; Epstein et al., 1966; Goto, 1997; Hatamochi, 2001).
These changes give skin a “tight, white, and shiny”
appearance, with a progressive sharpening of facial features
to give a “pinched”, “beaked”, or “bird-like” appearance (see
Figure 3 in Goto (2001)). The lower extremities, especially the
feet, may be markedly deformed with ulceration and
calciﬁcation of soft tissue and tendons (Hatamochi, 2001).
Many of these changes are readily apparent in patient
photos taken in early adulthood and later in life (Figure 1).
The progressive development of phenotype makes the
diagnosis of WS challenging, especially in young adults.
However, cardinal features are often present early, and they
can be used together with molecular conﬁrmation to conﬁrm
or exclude a diagnosis (Table 1; Hisama et al., 2014).
RELATED RECQ HELICASE DEFICIENCY SYNDROMES
The positional cloning of the WRN locus (Yu et al., 1996) and
other members of the RECQ helicase gene family led to the
recognition of deeper links between WS and two additional
genodermatoses: Bloom syndrome (BS; Ellis et al., 1995) and
Rothmund–Thomson syndrome (RTS; Kitao et al., 1999). BS
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patients display congenital short stature and a characteristic
sun-sensitive “butterﬂy” rash across the bridge of the nose and
cheeks that may involve hands and forearms (Bloom, 1954).
Many patients display cellular and humoral immune deﬁcits,
an elevated risk of otitis media, pneumonia, and diabetes
mellitus with reduced fertility. Cancer is the leading cause of
premature death (Bloom, 1954; German, 1979,1993, 1997).
RTS was ﬁrst described as a familial occurrence of skin
changes with bilateral juvenile cataracts (Rothmund, 1868;
Thomson, 1936; Taylor, 1957). A characteristic sun-sensitive
rash with redness, swelling, and blistering appears in the ﬁrst
year of life, and it may involve the buttocks and extremities
while sparing the chest, back, and abdomen. The rash may
further develop variable pigmentation, telangiectasia, and
WS patient 1 at ages 15 and 48 WS patient 2 at ages 13 and 56
Figure 1. Clinical features and progression of Werner syndrome. Left photo panels are of a Japanese-American WS patient reported by Epstein et al., 1966, at
ages 15 (left) and 48 (right) years. Right photo panels are of a Caucasian WS patient at ages ~ 13 (left) and 56 (right) years. Key clinical features of WS are present
in both sets of photos, including the rounded face, sharp facial features, graying, thinning, and loss of scalp and eyebrow hair, and in Patient 2, right panel, thin,
atrophic forearms and right elbow ulceration. Archival photos of patient 1, kindly provided by Drs George Martin and Nancy Hanson of the International Registry
of Werner Syndrome, were digitized and restored by Alden Hackmann. They are used courtesy of Lippincott Williams & Wilkins. Photos of patient 2 were
provided by Dr George Martin, and are used here courtesy of the patient’s spouse with informed consent of the patient, and of Elsevier Press where they were
originally published in different form (Martin, 2005).
Table 1. Diagnostic criteria of Werner syndrome
Category WS signs and symptoms1
Cardinal 1. Cataracts (bilateral)
2. Scleroderma-like skin changes
3. Short stature
4. Parental consanguinity
5. Premature graying and/or thinning of scalp hair
Additional 1. Diabetes mellitus
2. Hypogonadism
3. Osteoporosis
4. Osteosclerosis (distal phalanges/ﬁngers and/or toes)
5. Soft tissue calciﬁcation
6. Premature atherosclerosis
7. Neoplasia
8. Thin, high-pitched voice
Category Diagnostic conﬁdence Diagnostic criteria
Deﬁnite High conﬁdence All cardinal signs + two additional signs OR conﬁrmed pathogenic WRN mutations in both alleles
Probable High conﬁdence First three cardinal signs + any 2 others
Possible Low conﬁdence Either cataracts or dermatological changes + any 4 additional signs
Exclusion Exclude Signs or symptoms before adolescence (except stature)
1WS signs and symptoms are from the diagnostic criteria established by the International Registry of Werner Syndrome: www.wernersyndrome.org/registry/
diagnostic.html, with additional discussion and application provided in Lauper et al. (2013).
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focal atrophy. Hair, eyelashes, and eyebrows are often sparse
or absent. Congenital short stature is common, although less
severe than in BS. Developmental abnormalities include
dysplastic, malformed, or absent bones, often in the hand or
thumbs; delayed bone formation or bone density loss; and
malformed, missing, or extra teeth. Cataracts have been
documented in only a minority of contemporary RTS patients
(Wang et al., 2001; Larizza et al., 2010). Cancer risk is largely
limited to osteosarcoma (Wang et al., 2003; Siitonen et al.,
2009). Immunologic function appears intact, but fertility may
be reduced. Additional diseases associated with RECQL4
mutations are RAPADILINO and Baller–Gerold syndromes.
RAPADILINO syndrome patients have joint dislocations and
patellar hypoplasia or aplasia, but lack skin changes. Baller–
Gerold syndromes patients have craniosynostosis with radial
aplasia, and RTS-like skin changes (Siitonen et al., 2003; Van
Maldergem et al., 2006; Siitonen et al., 2009). Life expectancy
appears normal in the absence of cancer (Wang et al., 2001;
Larizza et al., 2010).
ELEVATED ACQUIRED DISEASE RISK IN WS
Many WS patients prematurely develop age-dependent
diseases such as myocardial infarction and stroke; cancer;
osteoporosis; diabetes mellitus; and hypogonadism. Cardio-
vascular disease and cancer are leading causes of premature
death (Goto, 1997; Goto et al., 2013). The elevated risk of
neoplasia is quite selective: two-thirds of neoplasms in WS
patients were of six, not obviously related, tumor types:
thyroid epithelial carcinomas, melanomas, meningiomas, soft
tissue sarcomas, hematologic neoplasia, chieﬂy leukemias,
and osteosarcoma (Lauper and Monnat, 2013; Lauper et al.,
2013; Monnat, 2013). Multiple neoplasms were common:
22% of 189 patients in our series had one to four concurrent
or sequential neoplasms, often of unusual types or at unusual
sites. For example, melanomas were almost exclusively less
common variants: acral lentiginous melanomas arising on the
palms, soles, or in nail beds, and mucosal melanomas arising
in the nasal cavity or esophagus. Thyroid neoplasms, in a
similar manner, were disproportionately less common
follicular carcinomas (Lauper et al., 2013). The excess
risk of these speciﬁc neoplasms, estimated using a
combination of standardized incidence ratio, proportional
incidence ratio analyses, ranged from nearly 60-fold
for melanoma to 1.5-fold for leukemia and preleukemic
disorders (Lauper et al., 2013). This spectrum of neoplasia
overlaps with, but is distinct from, the neoplasms observed in
BS and RTS (German, 1997; Monnat, 2001; Siitonen et al.,
2009). BS is unusual among heritable cancer predispositions,
as many different tumor types are involved (German, 1997;
Monnat, 2001). The cancer risk in the RTS-associated
RECQL4 syndromes is, conversely, restricted largely to
osteosarcoma and lymphoma (Wang et al., 2001, 2003;
Siitonen et al., 2009).
PHYSIOLOGIC ROLES OF RECQ HELICASES
All of the human RECQ helicases hydrolyze ATP, unwind
double-stranded DNA, and possess good DNA strand
annealing activity. WRN alone possesses an additional, 3ʹ to
5ʹ exonuclease activity. Despite their common biochemical
activities, the three disease-associated RECQ helicases
have differing substrate preferences and different sets of
protein partners (reviewed in Bachrati and Hickson,
2003; Brosh, 2013; Croteau et al., 2014; Sidorova and
Monnat, 2015). These biochemical data together with
functional and cellular data begin to indicate how these
seemingly similar proteins ﬁll different physiologic “niches” in
human cells and, by extension, how the loss of function of
one RECQ protein may lead to distinct cellular and
organismal phenotypes.
Functional characterizations have identiﬁed distinct roles in
speciﬁc RECQ helicase proteins in DNA replication. For
example, RECQL4 and, to a lesser extent, RECQL bind
replication origins and contribute to DNA replication initia-
tion (Thangavel et al., 2009; Xu et al., 2009). Single-molecule
DNA replication track analyses that we and others have
performed revealed roles for BLM, WRN, and RECQL in
replication fork rate maintenance and fork restart (Sidorova
et al., 2008; Berti et al., 2013; Sidorova et al., 2013). RECQL4
has an interesting additional role in mtDNA maintenance: it is
coimported with TP53, and it appears to limit mtDNA damage
in a replication-dependent manner (Croteau et al., 2012; De
et al., 2012; Gupta et al., 2014).
Several RECQ helicases also help maintain telomeres,
although they again display apparent functional specializa-
tion. Telomeric DNA poses a dual challenge to the DNA
replication machinery, as it is composed of repeated (the
human telomeric repeat sequence is TTAGGG), GC-rich
DNA organized into a unique chromatin “cap” at the ends
of chromosomes (Sfeir et al., 2009). G-rich lagging strands may
form G4 DNA quadruplex structures (Maizels and Gray,
2013), which are good biochemical substrates for WRN and
BLM. Only WRN helicase activity is required for complete
replication of telomeric G-rich lagging strands, whereas
cells lacking RECQL, RECQL4, or BLM also show telomere
breakage and loss. It is unclear whether these effects are
via a common mechanism (Crabbe et al., 2004, 2007;
Bareﬁeld and Karlseder, 2012; Ghosh et al., 2012;
Popuri et al., 2014). In contrast, WRN and BLM both
participate in the recombination-mediated “alternative length-
ening of telomeres” pathway used by many tumor cells to
gain replicative immortality (Mendez-Bermudez et al., 2012).
One phenomenon that is not yet well-understood is the
sensitivity of WRN+ cells to telomere-homologous DNA
oligonucleotides (“T-oligos”). The ability to respond to T-oligos
may depend upon WRN exonuclease activity, and may have
therapeutic potential in light of protective or deleterious
responses in different cell types (Eller et al., 2006; Gilchrest
and Eller, 2009).
All ﬁve of the human RECQ helicases also participate in
DNA double-strand break repair by nonhomologous DNA
end joining or homology-dependent recombination. WRN
and RECQL4 participate in base excision repair, and RECQL5
may have an additional role in ssDNA break repair (reviewed
in Brosh, 2013; Croteau et al., 2014; Sidorova and Monnat,
2015).
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“REWRITTEN IN THE SKIN”—RECQ HELICASES IN
TRANSCRIPTION
Previous analyses had suggested a role for the WRN and BLM
RECQ helicases in transcription (Kyng et al., 2003; Johnson
et al., 2010). To better understand this role, we analyzed gene
and miRNA expression in mutation-typed WS and BS primary
ﬁbroblasts and in isogenic control primary ﬁbroblasts
depleted of the WRN or BLM protein. These analyses
identiﬁed 3,000 genes and dozens of miRNAs whose
expression was signiﬁcantly altered by the loss of WRN and
BLM function. Among the subset (−25%) of genes altered in
both WS and BS cells, a surprisingly high fraction (490%)
had expression altered in the same direction (Nguyen et al.,
2014). Many WRN- and BLM-responsive downregulated
genes contained G quadruplex (G4) DNA motifs in their
5′ ends, providing strong evidence that G4 DNA structures
are physiologic, as well as biochemical, substrates for WRN
and BLM.
The genes and miRNAs altered in WS and/or BS cells have
important roles in pathways that drive cell growth, prolifera-
tion, death, and survival. BS patient cells had gene expression
patterns predicted to alter DNA replication recombination and
repair, as well as immune function and tumorigenic/DNA
damage signaling. These make good sense in light of our
understanding of the biochemical, cellular, and organismal
phenotype of BS (Nguyen et al., 2014; Tang, Robles et. al., in
preparation). WS appears more complex, and thus intriguing.
One remarkable—and as yet not fully understood—ﬁnding in
WS cells was coordinate upregulation of nearly all of the
cytoplasmic tRNA synthestase (ARS) and synthetase-associated
interacting protein (AIMP) genes (Park et al., 2010; Kim et al.,
2011; Wallen and Antonellis, 2013; Yao and Fox, 2013).
The mechanism of ARS/AIMP upregulation is not yet
understood but may include MYC, which can alter and in
turn be modulated by ARSs (Shi et al., 2014) while driving
expression of WRN and telomerase (Grandori et al., 2003).
ARS and AIMP overexpression in WS could perturb protein
homeostasis by altering global protein turnover and/or
translational ﬁdelity (Lee et al., 2014; Wolff et al., 2014).
Altered tRNA charging could affect the balance between
mitochondrial and nuclear protein synthesis to promote
mitochondrial dysfunction and oxidative stress (Jovaisaite
and Auwerx, 2015). It could also drive disease pathogenesis
via the growing list of ARS/AIMP “noncanonical” functions
that modulate disease-related metabolic, developmental,
angiogenic, tumorigenic, immune, and inﬂammatory path-
ways (Paul and Schimmel, 2013; Son et al., 2014). All of these
areas are ripe for further exploration using a combination of
new genomic and proteomic approaches.
THE ORIGINS OF PHENOTYPE
The biochemical and cellular specializations of the individual
RECQ helicases outlined above begin to indicate how the loss
of function of a single RECQ protein may lead to speciﬁc
RECQ deﬁciency syndromes and their associated disease
risks. As noted above, RECQ-deﬁcient cells display cell
proliferation defects in conjunction with genomic instability
(Martin et al., 1970; Warren et al., 1981; Dhillon et al., 2007;
Sharma et al., 2007; Thangavel et al., 2009; Mao et al., 2010;
Sidorova et al., 2013). These cellular defects in turn are likely
part of the explanation for why BS and RTS patients are often
small, although proportionately developed. BLM or RECQL4
loss can both interfere with DNA replication and impair cell
production throughout development. Despite this,
development appears to be largely normal in both
syndromes, and it responds by proportionately scaling
output (the fetus) to reﬂect inadequate substrate (cells). This
proportional dwarﬁng is particularly striking in BS, where
patients are born and often remain at or below the 5th
percentile for height and weight (Keller et al., 1999).
The progressive development of progeroid features in WS
only after development is largely complete may reﬂect the
starkly different outcome of replication arrest, which leads to
high levels of cell death in BS, although not in WS, cells (Mao
et al., 2010; Sidorova et al., 2013). WRN loss, in contrast, has a
more profound effect on transcription than does BLM loss, and
thus may have a correspondingly more prominent role in
transcription and tissue maintenance (see above). Disrupted
DNA metabolism in WS patient cells could drive the
progressive accumulation of mutant and senescent cells in
many tissues, with acquisition of a senescence-associated
secretory phenotype that could in turn promote the elevated
risk of many clinically important age-associated diseases
(Campisi, 2013). Cellular senescence in the RECQ helicase
syndromes may have one modest silver lining: it is an effective,
albeit nonspeciﬁc, tumor-suppressive mechanism (Adda di
Fagagna, 2008; Collado and Serrano, 2010). Altered RECQ
expression, as opposed to mutation, may be frequent in many
tumor types (Lao et al., 2013). However, the previous
suggestion that these changes may be largely methylation-
driven (Agrelo et al., 2006) has not been consistent enough in
our hands to serve as a reliable marker for altered WRN
expression in tumors (Lao et al., 2013).
More systematic collection of patient data, longitudinal
study of patients, and the collection and distribution of well-
characterized clinical samples should all aid our under-
standing of the RECQ deﬁciency syndromes. We also have a
growing range of options to capture and analyze patient-
derived cells and cell lines, including improved short-term
primary culture, organoid culture, and the generation of cell
lines and iPS cells (Martin et al., 1970; Wyllie et al., 2000;
Cheung et al., 2014; Shimamoto et al., 2014). These analyses
and materials have the potential to identify genetic and
environmental modiﬁers of disease progression and acquired
disease risk.
NEW CLUES TO SKIN BIOLOGY, DISEASE, AND THERAPY
The above analyses emphasize the complexity of disease
pathogenesis in even “simple” monogenic genetic diseases
such as WS. They also emphasize how new insights
into disease pathogenesis from rare heritable diseases
may improve our understanding of skin biology while
identifying potential new therapies. One example comes
from another skin disease, recessive dystrophic epidemolysis
bullosa. Recessive dystrophic epidemolysis bullosa results
from COL7A1 mutations leading to loss of Type VII
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collagen, a marked reduction in anchoring ﬁbrils, and
extreme skin fragility with loss and scarring (Tolar and
Wagner, 2013).
The potential for genetic therapies of epidermolysis bullosa
and a handful of other heritable diseases was emphasized
over two decades ago by the identiﬁcation of patients who
had undergone spontaneous reversion of causative mutations
with partial or full correction of disease-speciﬁc defects in
skin, blood, lymphoid, or liver (Hirschhorn, 2003). A deeper
understanding of the role of Type VII collagen in skin (Tolar
and Wagner, 2013) had led to a diversity of therapeutic
approaches: complementation (GENEGRAFT, 2014) or
targeted correction of causative COL7A1 mutations in
epidermal cells (Sebastiano et al., 2014); the use of patient-
derived, mutation-reverted keratinocytes (Tolar et al., 2014);
and the repair in trans of anchoring ﬁbrils using allogeneic
ﬁbroblasts (Venugopal et al., 2013), mutation-corrected, iPS-
derived ﬁbroblasts (Wenzel et al., 2014), or bone marrow
transplantation (Wagner et al., 2010; Tolar and Wagner,
2013; ). Repair in trans may be a viable option for dealing
with the scleroderma-like skin changes seen in WS, as might
aminoglycoside suppression of WRN missense mutations, a
strategy that has been used in recessive dystrophic epidemo-
lysis bullosa (Cogan et al., 2014).
Another unusual example of where we may ﬁnd new
clues to treating heritable or acquired skin disease, as well as
age-associated changes, comes from comparative genetics,
more speciﬁcally the African spiny mice Acomys kempi and
Acomys percivali. Acomys mice have the remarkable ability
to shed–and then regenerate without scarring–large segments
of skin, and may have evolved this ability to escape
predators (Seifert et al., 2012). Although scarless wound
healing also occurs in humans, it is largely restricted to the
fetus (Yates et al., 2012). Acomys mice, in contrast, are able to
continuously regenerate skin without scarring in the face of
injury, inﬂammation, and infection. Understanding the
mechanistic basis for this remarkable example of
epimorphic regeneration may identify new ways to maintain
or rejuvenate skin, and to help individuals with injuries that
lead to disﬁguring scarring. Nature undoubtedly holds more
examples of remarkable cutaneous biology. Finding these and
turning them to good use will require imagination, together
with a willingness to look—and think—a bit beyond our usual
comfort zone.
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